Nuclera Ltd – Trademark Portfolio
Entity Type: 99
Nuclera Ltd holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 7 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include EDNA, EDROP, EGENE, NUCLERA, and EPROTEIN.
One Vision Park,
Station Road Impington, Cambridge CB24 9NP
Showing of trademarks Trademarks
Trademark Classifications
Nuclera Ltd's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Nuclera Ltd have?
Nuclera Ltd has 9 U.S. trademarks filed with the USPTO. Of these, 9 registered.
What trademark classes does Nuclera Ltd file in?
Nuclera Ltd files trademarks across 7 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Nuclera Ltd's most well-known trademarks?
Nuclera Ltd's registered trademark portfolio includes well-known marks such as EDNA, EDROP, EGENE, NUCLERA, and EPROTEIN. These are among 9 currently registered trademarks in the portfolio.
What is Nuclera Ltd's trademark registration success rate?
Nuclera Ltd has a 100% trademark registration rate, with 9 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.